Champions Oncology (CSBR) Operating Margin Growth (3y) (2013 - 2026)
Champions Oncology (CSBR) Operating Margin Growth (3y) (2013 - 2026) Analysis & Trends
Peer Comparison
| # |
Company |
Market Cap |
Enterprise Value |
Gross Profit (Qtr) |
Operating Margin Growth (3y) (Qtr) |
| 1 |
Alterity Therapeutics |
719,706.53 Bn |
719,706.50 Bn |
- |
- |
| 2 |
Belite Bio |
55,800.00 Bn |
55,800.00 Bn |
- |
- |
| 3 |
Quantum Biopharma |
18,182.30 Bn |
18,182.29 Bn |
- |
- |
| 4 |
Legend Biotech |
3,154.00 Bn |
3,153.71 Bn |
242.10 Mn |
-40,178.00 |
| 5 |
Akari Therapeutics |
1,844.30 Bn |
1,844.29 Bn |
- |
- |
| 6 |
Evaxion A |
1,567.96 Bn |
1,567.94 Bn |
- |
- |
| 7 |
Psyence Biomedical |
251.43 Bn |
251.42 Bn |
- |
- |
| 8 |
Vertex Pharmaceuticals |
112.56 Bn |
105.31 Bn |
2.59 Bn |
530.00 |
| 9 |
Abivax |
94.37 Bn |
94.37 Bn |
- |
- |
| 10 |
Champions Oncology |
78.46 Mn |
71.46 Mn |
13.89 Mn |
1,758.00 |
| Date | Value |
|---|
| Jan 31, 2026 |
1,758.00 |
| Oct 31, 2025 |
118.00 |
| Jul 31, 2025 |
-170.00 |
| Apr 30, 2025 |
-1,383.00 |
| Jan 31, 2025 |
2,011.00 |
| Oct 31, 2024 |
320.00 |
| Jul 31, 2024 |
1,101.00 |
| Apr 30, 2024 |
420.00 |
| Jan 31, 2024 |
-3,052.00 |
| Oct 31, 2023 |
-1,696.00 |
| Jul 31, 2023 |
-2,057.00 |
| Apr 30, 2023 |
392.00 |
| Jan 31, 2023 |
-2,405.00 |
| Oct 31, 2022 |
-377.00 |
| Jul 31, 2022 |
705.00 |
| Apr 30, 2022 |
-91.00 |
| Jan 31, 2022 |
1,205.00 |
| Oct 31, 2021 |
-188.00 |
| Jul 31, 2021 |
-928.00 |
| Apr 30, 2021 |
604.00 |
